Search
for
Sort by
Research 451–480 of 1000+
- Alopecia Areata: Evidence-Based Treatments
- Comparison of Alopecia areata in Human and Nonhuman Mammalian Species
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Drug discovery for alopecia: gone today, hair tomorrow
- Efficacy and tolerability of methotrexate in severe childhood alopecia areata
- A mixed methods survey of social anxiety, anxiety, depression and wig use in alopecia
- Neuroendocrine Perspectives in Alopecia Areata: Does Stress Play a Role?
- Controlled Delivery of T-box21 Small Interfering RNA Ameliorates Autoimmune Alopecia (Alopecia Areata) in a C3H/HeJ Mouse Model
- Development of Alopecia Areata Universalis in a Patient Receiving Adalimumab
- Alopecia areata − animal models
- Topical Cyclosporine in Alopecia Areata
- Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Ceramide synthase 4 deficiency in mice causes lipid alterations in sebum and results in alopecia
- Targeted Skin Overexpression of the Mineralocorticoid Receptor in Mice Causes Epidermal Atrophy, Premature Skin Barrier Formation, Eye Abnormalities, and Alopecia
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Alopecia areata: An update
- Alopecia areata: a new treatment plan
- Clinical evaluation of alopecias using a handheld dermatoscope
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Investigative guidelines for alopecia areata
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild‐to‐moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator‐blinded trial
- Primary cicatricial alopecia
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- The Therapeutic Effect and the Changed Serum Zinc Level after Zinc Supplementation in Alopecia Areata Patients Who Had a Low Serum Zinc Level
- Twice Weekly 5 mg Dexamethasone Oral Pulse in the Treatment of Extensive Alopecia Areata
- Immune deficiency–related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency